News | December 27, 2025
Symbiosis rolls out first 10,000 vial batch at Stirling Facility
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
This production milestone positions Symbiosis at the forefront of meeting rising global demand for life-saving medicines
The approval makes AQVESME the only FDA-approved therapy for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia
The move strengthens Sanofi’s presence in adult immunization by combining Dynavax’s innovative vaccines with Sanofi’s global scale and development capabilities
Afrezza comes in single-use cartridges, delivered via a simple inhaler device. Users select the appropriate cartridge, load it, inhale the insulin, and remove the cartridge
The Phase 1 study will evaluate the safety, tolerability, and pharmacokinetics (PK) of ENV-6946 in healthy volunteers
Additional investments planned to expand the site’s capacity and capabilities to support growing manufacturing programs
The study is being conducted under a USFDA IND, has received U.S. Fast Track Designation for SLE-ITP, and has obtained IND approval from China’s Center for Drug Evaluation
The approval for Exdensur (depemokimab-ulaa) comes on the back of SWIFT-1 and SWIFT-2 Phase III trials
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
The expansion includes a larger technical and service team and increased local procurement
Subscribe To Our Newsletter & Stay Updated
